Dr Michael Schneider, chairman of the management board of NORMA Group, a global market leader in engineered joining technology, is currently receiving medical treatment for the respiratory disease COVID-19 due to a coronavirus infection. He will not be able to perform his tasks for the time being. The company has immediately initiated measures to protect its employees and is in discussions with the responsible health authority regarding further steps.(…)
via NORMA Group CEO Michael Schneider has contracted COVID-19 | Fastener + Fixing Magazine.